5,183 Shares in DocuSign, Inc. (NASDAQ:DOCU) Bought by Cassaday & Co Wealth Management LLC

Cassaday & Co Wealth Management LLC purchased a new position in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 5,183 shares of the company's stock, valued at approximately $466,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Itau Unibanco Holding S.A. acquired a new position in DocuSign in the third quarter valued at approximately $28,000. Kestra Investment Management LLC acquired a new position in shares of DocuSign in the 4th quarter valued at $30,000. Brooklyn Investment Group purchased a new position in shares of DocuSign in the 3rd quarter valued at $33,000. Modus Advisors LLC acquired a new stake in DocuSign during the 4th quarter worth $36,000. Finally, Avion Wealth raised its stake in DocuSign by 309.2% during the 4th quarter. Avion Wealth now owns 487 shares of the company's stock worth $43,000 after acquiring an additional 368 shares in the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.

DocuSign Trading Down 2.9 %

NASDAQ:DOCU traded down $2.46 on Tuesday, hitting $81.24. 1,399,123 shares of the stock were exchanged, compared to its average volume of 2,019,095. The stock has a market cap of $16.41 billion, a PE ratio of 16.74, a PEG ratio of 6.94 and a beta of 0.89. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86. The stock has a fifty day moving average of $91.45 and a 200-day moving average of $77.09.

Insider Buying and Selling

In related news, CFO Blake Jeffrey Grayson sold 8,000 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $86.90, for a total value of $695,200.00. Following the completion of the sale, the chief financial officer now directly owns 77,851 shares in the company, valued at approximately $6,765,251.90. This represents a 9.32 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Peter Solvik sold 10,000 shares of the business's stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $91.26, for a total value of $912,600.00. Following the transaction, the director now owns 150,253 shares in the company, valued at approximately $13,712,088.78. This represents a 6.24 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 693,773 shares of company stock valued at $66,727,926. 1.66% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on DOCU shares. Wells Fargo & Company raised their price objective on DocuSign from $50.00 to $70.00 and gave the stock an "underweight" rating in a report on Friday, December 6th. Hsbc Global Res raised DocuSign to a "moderate sell" rating in a research report on Friday, December 6th. UBS Group lifted their price target on shares of DocuSign from $60.00 to $100.00 and gave the company a "neutral" rating in a research report on Friday, December 6th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $90.00 price objective (up from $57.00) on shares of DocuSign in a research report on Friday, December 6th. Finally, HSBC reiterated a "reduce" rating on shares of DocuSign in a research report on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, DocuSign presently has an average rating of "Hold" and an average target price of $92.45.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.